# Meal-regulated Substrate Metabolism, Influence of Obesity and IL-6

> **NCT04687540** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 25 (actual)

## Conditions studied

- Obesity
- Healthy

## Interventions

- **DRUG:** Tocilizumab
- **DRUG:** Saline 0.9%

## Key facts

- **NCT ID:** NCT04687540
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-09
- **Primary completion:** 2021-08-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04687540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04687540, "Meal-regulated Substrate Metabolism, Influence of Obesity and IL-6". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04687540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*